{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:46:18Z","timestamp":1767865578423,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.yrtph.2009.01.009","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T04:30:39Z","timestamp":1233376239000},"page":"23-42","source":"Crossref","is-referenced-by-count":71,"title":["Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities"],"prefix":"10.1016","volume":"54","author":[{"given":"Edwin J.","family":"Matthews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carling J.","family":"Ursem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi L.","family":"Kruhlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Daniel","family":"Benz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Aragon\u00e9s","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihae","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Klopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Contrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2009.01.009_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2165\/00002018-200629100-00005","article-title":"Comparative performance of two quantitative safety signaling methods","volume":"29","author":"Almenoff","year":"2006","journal-title":"Drug Saf."},{"key":"10.1016\/j.yrtph.2009.01.009_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1289\/ehp.96104s51101","article-title":"Prediction of rodent carcinogenicity for 30 chemicals","volume":"104","author":"Ashby","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2009.01.009_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/mutage\/9.1.7","article-title":"Prediction of rodent carcinogenicity for 44 chemicals","volume":"9","author":"Ashby","year":"1994","journal-title":"Mutagenesis"},{"key":"10.1016\/j.yrtph.2009.01.009_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1383-5742(97)00021-5","article-title":"The first US National Toxicology Program exercise on the prediction of rodent carcinogenicity: definitive results. 4. Prediction of non-lethal mammalian toxicological and points, and expert systems for toxicity prediction","volume":"387","author":"Bager","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2009.01.009_bib5","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/cr030049y","article-title":"Structure activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches","volume":"105","author":"Benigni","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yrtph.2009.01.009_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/17425255.3.1.109","article-title":"Toxicological and clinical computational analysis and the US FDA\/CDER","volume":"3","author":"Benz","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1289\/ehp.96104s51001","article-title":"The NIEHS predictive-toxicology evaluation project","volume":"104","author":"Bristol","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2009.01.009_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yrtph.2007.07.001","article-title":"Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR Models","volume":"49","author":"Contrera","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1979.10","volume":"39","author":"Cooper","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yrtph.2009.01.009_bib10","unstructured":"COSTART. 1995. Coding Symbols for Thesaurus of Adverse Reaction Terms, fifth ed., Department of Health and Human Services: Rockville, MD."},{"key":"10.1016\/j.yrtph.2009.01.009_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2307\/2686093","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am. Stat."},{"key":"10.1016\/j.yrtph.2009.01.009_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidem. Drug Saf."},{"key":"10.1016\/j.yrtph.2009.01.009_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/01926230500321213","article-title":"A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity","volume":"33","author":"Fielden","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/009286150103500134","article-title":"Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999","volume":"25","author":"Fung","year":"2001","journal-title":"Drug Inform. J."},{"key":"10.1016\/j.yrtph.2009.01.009_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1020869118689","article-title":"Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection","volume":"16","author":"Golbraikh","year":"2002","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.yrtph.2009.01.009_bib16","series-title":"Computational Toxicology: Risk Assessment for Pharmaceuticals and Environmental Chemicals","first-page":"183","article-title":"Computational Approaches for Assessment of Toxicity\u2014A Historical Perspective and Current Status","author":"Gombar","year":"2007"},{"key":"10.1016\/j.yrtph.2009.01.009_bib17","first-page":"307","article-title":"Receiver operating characteristic (ROC) methodology: the state of the art","volume":"29","author":"Hanley","year":"1989","journal-title":"Crit. Rev. Diagn. Imaging"},{"key":"10.1016\/j.yrtph.2009.01.009_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2006.10.008","article-title":"Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products","volume":"59","author":"Kruhlak","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yrtph.2009.01.009_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2003-42641","article-title":"Acute liver failure in the United States","volume":"23","author":"Lee","year":"2003","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.yrtph.2009.01.009_bib20","unstructured":"Lee, W.M., 2005. Drug-induced acute liver failure in the US 2005: results from the US acute liver failure study group. Available from: <http:\/\/www.fda.gov\/cder\/livertox\/presentations2005\/William_Lee.ppt>."},{"key":"10.1016\/j.yrtph.2009.01.009_bib21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.171.3977.1217","article-title":"Signal detectability and medical decision-making","volume":"171","author":"Lusted","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2009.01.009_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/rtph.1998.1259","article-title":"A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software","volume":"28","author":"Matthews","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/17425255.3.1.125","article-title":"In silico approaches to explore toxicity endpoints: Issues and concerns for estimating human health effects","volume":"3","author":"Matthews","year":"2007","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/15376510701857379","article-title":"Combined use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows software to achieve high performance, high confidence, mode of action-based predictions of chemical carcinogenesis in rodents","volume":"18","author":"Matthews","year":"2008","journal-title":"Toxicol. Mechan. Methods"},{"key":"10.1016\/j.yrtph.2009.01.009_bib25","doi-asserted-by":"crossref","unstructured":"Matthews, E.J., Kruhlak, N.L., Benz, R.D., Contrera, J.F., Marchant, C.A., David Aragon\u00e9s Sabat\u00e9. 2009. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: C: Use of (Q)SAR and Expert systems for estimation of the mechanism of action of drug-induced urinary tract and hepatobiliary toxicities. Regul. Toxicol. Pharmacol, in press, doi:10.1016\/j.yrtph.2009.01.007.","DOI":"10.1016\/j.yrtph.2009.01.007"},{"key":"10.1016\/j.yrtph.2009.01.009_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yrtph.2006.11.002","article-title":"A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR database","volume":"47","author":"Matthews","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yrtph.2006.10.001","article-title":"A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals","volume":"47","author":"Matthews","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yrtph.2005.11.003","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yrtph.2005.10.004","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1570163043334794","article-title":"Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling","volume":"1","author":"Matthews","year":"2004","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pds.1058","article-title":"The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions","volume":"14","author":"Moore","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.yrtph.2009.01.009_bib32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2009.01.009_bib33","unstructured":"OECD, 2007. Guidance document on the validation of (quantitative) structure-activity relationship [(Q)SAR] models. OECD environment health and safety publications series on testing and assessment No. XX. Draft."},{"key":"10.1016\/j.yrtph.2009.01.009_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1568026013395074","article-title":"Integration of computational analysis as a sentinel tool in toxicological assessments","volume":"1","author":"Pearl","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.yrtph.2009.01.009_bib35","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1897\/01-171","article-title":"Quantitative structure-activity relationship methods: Perspectives on drug discovery and toxicology","volume":"22","author":"Perkins","year":"2003","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.yrtph.2009.01.009_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1007601015854","article-title":"Robust classification for imprecise environments","volume":"42","author":"Provost","year":"2001","journal-title":"Machine Learn. J."},{"key":"10.1016\/j.yrtph.2009.01.009_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA\u2019s spontaneous reports database","volume":"25","author":"Szarfman","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.yrtph.2009.01.009_bib38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1592\/phco.24.13.1099.38090","article-title":"Pharmacovigilance in the 21st century: new systematic tools for an old problem","volume":"24","author":"Szarfman","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.yrtph.2009.01.009_bib39","unstructured":"Temple, R.J., 2001. Hepatotoxicity through the years: impact on the FDA. Available from: <http:\/\/www.fda.gov\/cder\/livertox\/presentations\/im1389\/sld001.htm>."},{"key":"10.1016\/j.yrtph.2009.01.009_bib40","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/es049220t","article-title":"Practical considerations on the use of predictive models for regulatory purposes","volume":"39","author":"Tunkel","year":"2005","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.yrtph.2009.01.009_bib41","doi-asserted-by":"crossref","unstructured":"Ursem, C.J., Matthews, E.J., Kruhlak, N.L., Contrera, J.F., Benz, R.D., 2009. Identification of structure activity relationships for adverse effects of pharmaceuticals in humans A: Use of FDA post market reports to create a database of hepatobiliary and urinary tract toxicities. Regul. Toxicol. Pharmacol, in press, doi:10.1016\/j.yrtph.2008.12.009","DOI":"10.1016\/j.yrtph.2008.12.009"},{"key":"10.1016\/j.yrtph.2009.01.009_bib42","unstructured":"US EPA, Office of Pollution Prevention and Toxics, 1999. The use of structure-activity relationships (SAR) in the high production volume chenmicals challenge program. Available from: <http:\/\/www.epa.gov\/chemrtk\/sarfinl1.htm>."},{"key":"10.1016\/j.yrtph.2009.01.009_bib43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/mutage\/geh043","article-title":"3 new consensus QSAR models for the prediction of Ames genotoxicity","volume":"19","author":"Votano","year":"2004","journal-title":"Mutagenesis"},{"key":"10.1016\/j.yrtph.2009.01.009_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-197816010-00002","article-title":"Drug-induced liver disease","volume":"16","author":"Zimmerman","year":"1978","journal-title":"Drugs"},{"key":"10.1016\/j.yrtph.2009.01.009_bib45","series-title":"Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver","author":"Zimmerman","year":"1999"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230009000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230009000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T14:12:59Z","timestamp":1558102379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230009000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0273230009000130"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2009.01.009","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}